GRDN
Guardian Pharmacy Services, Inc.
49.98
+0.13 (+0.26%)
52w low 26.34
50.17 high
99.2% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 344.33M | 377.43M | 397.62M | 336.60M | 351.77M | |
| Cost of Revenue | -- | 276.19M | 302.71M | 312.11M | 260.29M | 271.72M | |
| Gross Profit | -- | 68.15M | 74.72M | 85.50M | 76.31M | 80.04M | |
| Operating Expenses | -- | 55.57M | 58.37M | 54.74M | 58.63M | 59.40M | |
| SG&A | -- | 55.57M | 58.37M | 54.74M | 58.63M | 59.40M | |
| Operating Income | -- | 12.58M | 16.35M | 30.76M | 17.68M | 20.64M | |
| EBITDA | -- | 18.25M | 22.63M | 37.00M | 24.42M | 35.75M | |
| Pretax Income | -- | 12.59M | 16.63M | 31.10M | 18.29M | 29.79M | |
| Income Tax | -- | 3.76M | 7.04M | 9.83M | 4.75M | 7.67M | |
| Net Income | -- | 9.03M | 9.82M | 20.92M | 13.29M | 21.87M | |
| EPS Diluted | -- | 0.14 | 0.15 | 0.33 | 0.21 | 0.34 | |
| Diluted Shares | -- | 63.20M | 63.43M | 63.62M | 63.69M | 63.84M |
Revenue CAGR
+0.5%
Net Income CAGR
+24.8%
EPS CAGR
+24.8%
FCF CAGR
+12.9%
Revenue YoY
+4.5%